Cargando…
Association between miRNA signatures in serum samples from epidermal growth factor inhibitor treated patients and skin toxicity
Objective: Epidermal growth factor receptor inhibitors (EGFRI) are used as targeted cancer therapy. On average 70% of patients treated with EGFRIs suffer from skin toxicity. Studies showed a correlation between overall survival and the appearance of a skin rash, which is used as a biomarker for ther...
Autores principales: | Kemski, Sarah, Molitor, Vivien, Steffens, Michael, Nümm, Tim J., Herrmann, Nadine, Hornung, Thorsten, Bieber, Thomas, Schumann, Christian, Kächele, Volker, Seufferlein, Thomas, Heinemann, Volker, Scholl, Catharina, Stingl, Julia Carolin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121613/ https://www.ncbi.nlm.nih.gov/pubmed/34012511 http://dx.doi.org/10.18632/oncotarget.27953 |
Ejemplares similares
-
Predictive blood plasma biomarkers for EGFR inhibitor-induced skin rash
por: Hichert, Vivien, et al.
Publicado: (2017) -
Population nutrikinetics of green tea extract
por: Scholl, Catharina, et al.
Publicado: (2018) -
Altered Serum Phospholipids in Atopic Dermatitis and Association with Clinical Status
por: Sakai, Takashi, et al.
Publicado: (2021) -
Adverse Drug Reactions in the Emergency Department: Is There a Role for Pharmacogenomic Profiles at Risk?—Results from the ADRED Study
por: Just, Katja S., et al.
Publicado: (2020) -
CYP2D6 in the Brain: Potential Impact on Adverse Drug Reactions in the Central Nervous System—Results From the ADRED Study
por: Just, Katja S., et al.
Publicado: (2021)